Clinical trial
A Phase 1/2 Prospective, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution, in Improving Distance Corrected Near Vision in Subjects With Presbyopia
NCT02516306 is registered in ClinicalTrials.gov with Encore Vision, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1/2 Prospective, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution, in Improving Distance Corrected Near Vision in Subjects With Presbyopia
- Lead sponsor
- Encore Vision, Inc.
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- September 16, 2015
- Completion date
- March 10, 2016
- Enrollment
- 75 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.